Skip to main content
. 2020 Dec 23;10:582092. doi: 10.3389/fonc.2020.582092

Figure 4.

Figure 4

PSA (ng/mL) at time of imaging (A) and PSAdt (months) (B) in patients without versus with PET-positive lesions (score 2 or 3).